Accord Logo

Intended for UK patients and members of the public

Codeine Phosphate Tablets

Active Ingredients

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Codeine phosphate Tablets BP 15mg

PL Number:
0142/6458 R
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Description of update: To add full product description in SmPC Section 3, Add: `White, circular, biconvex uncoated tablets impressed "C" on one face and the identifying letters "CO" on the reverse.' Only SmPC Section 3 is updated. PIL is not affected.

    SmPC sections updated: 3 and 10.

  • Description of update: To amend the packaging components without the need to amend the SmPC. Changes notified are: To register the replacement of the leaflet aligning the product description in Section 6 with section 3 of the SmPC. To replace ‘’Codeine Phosphate 15mg Tablets are white, uncoated tablets.’’ with ‘’Codeine Phosphate 15mg Tablets are white, circular, biconvex uncoated tablets impressed "C" on one face and the identifying letters "CO" on the reverse.’’ Additional editorial changes applied in the leaflet: semicolon replaced with colon.

    PIL sections updated: 2, 4 and 6.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Codeine phosphate Tablets BP 30mg

PL Number:
0142/6459 R
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Variation Description: To register M.3.2.P.7 Container Closure System for 20μ Aluminium/250μ PVC blister packaging. Amendments are also made to 3.2.P.1 and SmPC section 6.5.

    Note: 3.2.P.1 and SmPC 6.5 have been updated to remove details of heat seal lacquer.

    SmPC section(s) updated– 6.5, 10

    No changes to artwork

  • Description of update: To amend the packaging components without the need to amend the SmPC. Changes notified are: To register the replacement of the leaflet aligning the product description in Section 6 with section 3 of the SmPC. To replace ‘’Codeine Phosphate 15mg Tablets are white, uncoated tablets.’’ with ‘’Codeine Phosphate 15mg Tablets are white, circular, biconvex uncoated tablets impressed "C" on one face and the identifying letters "CO" on the reverse.’’ Additional editorial changes applied in the leaflet: semicolon replaced with colon.

    PIL sections updated: 2, 4 and 6.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Codeine phosphate Tablets BP 60mg

PL Number:
0142/6548 R
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Variation Description: To register M.3.2.P.7 Container Closure System for 20μ Aluminium/250μ PVC blister packaging. Amendments are also made to 3.2.P.1 and SmPC section 6.5.

    Note: 3.2.P.1 and SmPC 6.5 have been updated to remove details of heat seal lacquer.

    SmPC section(s) updated– 6.5, 10

    No changes to artwork

  • Description of update: To amend the packaging components without the need to amend the SmPC. Changes notified are: To register the replacement of the leaflet aligning the product description in Section 6 with section 3 of the SmPC. To replace ‘’Codeine Phosphate 15mg Tablets are white, uncoated tablets.’’ with ‘’Codeine Phosphate 15mg Tablets are white, circular, biconvex uncoated tablets impressed "C" on one face and the identifying letters "CO" on the reverse.’’ Additional editorial changes applied in the leaflet: semicolon replaced with colon.

    PIL sections updated: 2, 4 and 6.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

General FAQs

For any further assistance, please get in touch.

View product information as a: